Experts continue to debate whether the health status benefits are real and enough to justify doing the procedures for severe ...
While Natera said it will seek FDA approval for Signatera based on data from IMvigor011, the readout from another ctDNA-guided de-escalation study was more nuanced.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback